BIO Events
Patient advocacy drives innovation: James Roe’s asthma story comes to BIO 2026
When BIO President & CEO John F. Crowley met INDY NXT racer James Roe at a Notre Dame game, something clicked. It wasn’t a shared ...
Read More
Latest News
LATEST STORIES
Federal Policy
Section 232 tariff uncertainty remains high as onshoring plan deadline looms
Strengthening America’s biopharma manufacturing base and biotechnology leadership are goals both BIO and the Trump administration share. But as companies work to advance those aims ...
Federal Policy
Lawmakers warn against weakening IP for medicines in House hearing
Lawmakers defended strong IP protections as essential to biotech innovation that saves lives in a June 4 Congressional hearing that also considered the role of ...
BIO's View
House hearing to examine bill balancing data privacy and R&D needs
Researchers utilize health data to inform medical breakthroughs, but patients need to know their personal information stays confidential. The current patchwork of state laws regulating ...
WHAT YOU MISSED AT THE LATEST BIO EVENTS
Patient advocacy drives innovation: James Roe’s asthma story comes to BIO 2026
When BIO President & CEO John F. Crowley met INDY NXT racer James Roe at a Notre Dame game, something clicked. It wasn’t a shared ...
Read More
State of play: BIO Coffee Chat covers how state policies impact access
“We’re finding that the most disruptive pieces of legislation are much more likely to advance in state legislatures first, before eventually gaining traction at the ...
Read More